PATENT CLAIM ANALYSIS

Application Number: 16220766
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "567000"]

Abstract:
The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.

Claim (Index 30):
A method of treating a disease comprising administering a pharmaceutical composition into the mouth of a patient via continuous or frequent intermittent administration for a period of at least 4 hours, said method comprising:\n (i) inserting a drug delivery device into the mouth of a patient; (ii) administering said pharmaceutical composition into the mouth of said patient via continuous or frequent continuous administration at a rate between 0.001 mL/hour and 1.25 mL/hour for a period of at least 4 hours; and (iii) removing said drug delivery device from the mouth of said patient; wherein said pharmaceutical composition comprises a dynamic viscosity greater than 100 poise at 37\u00b0 C., and greater than about 35% (w/w) drug, and wherein the fluctuation index of said drug is less than or equal to 2.0 during the delivery period.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.24
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15887243', '15448208', '15757217', '15001392', '14230067']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7129024136897514
- 35 USC 102 Novelty (BERT): 0.567477832149089
- Combined Prediction Score: 0.6983599555356852
- Mean Citation Score: 299.453384
- Max Citation Score: 490.65085
- Similarity Product: 309.59272303452195

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test